0001485003-21-000158.txt : 20210721 0001485003-21-000158.hdr.sgml : 20210721 20210721173717 ACCESSION NUMBER: 0001485003-21-000158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210720 FILED AS OF DATE: 20210721 DATE AS OF CHANGE: 20210721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Honig Peter CENTRAL INDEX KEY: 0001484780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 211105393 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES COURT, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_162690342009283.xml FORM 4 X0306 4 2021-07-20 0 0001485003 Sesen Bio, Inc. SESN 0001484780 Honig Peter C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 0 0 0 Stock Option 3.86 2021-07-20 4 A 0 185000 0 A 2031-07-20 Common Stock 185000.0 185000 D The option was granted on July 20, 2021 and vests monthly in equal amounts over a three-year period following the grant date. Based on market analysis by Radford of public, pre-commercial biopharmaceutical companies with less than 200 employees and market values between $250 million and $1 billion, the compensation committee of Sesen Bio, Inc. (the "Company") recommended to the Company's board of directors, and the board of directors approved, the amount of the initial grant to the reporting person in connection with the reporting person's appointment as a non-employee director. s/ Mark R. Sullivan, as attorney-in-fact 2021-07-21